Published in Ann Surg on June 01, 1994
Preoperative neck ultrasonographic mapping for persistent/recurrent papillary thyroid cancer. World J Surg (2004) 0.94
Upregulation of the signal transducers and activators of transcription 3 (STAT3) pathway in lymphatic metastases of papillary thyroid cancer. Int J Clin Exp Pathol (2011) 0.86
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement. Eur J Nucl Med Mol Imaging (2007) 0.85
Recurrent differentiated thyroid cancer: to cut or burn. World J Surg Oncol (2011) 0.82
Risk Factors for Recurrence in Filipinos with Well-Differentiated Thyroid Cancer. Endocrinol Metab (Seoul) (2015) 0.80
Prognostic factors in patients with multiple recurrences of well-differentiated thyroid carcinoma. J Oncol (2009) 0.78
Radio-guided surgery for persistent differentiated papillary thyroid cancer: case presentations and review of the literature. Langenbecks Arch Surg (2006) 0.75
Recurrence Incidence in Differentiated Thyroid Cancers and the Importance of Diagnostic Iodine-131 Scintigraphy in Clinical Follow-up. Mol Imaging Radionucl Ther (2016) 0.75
Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma. Rambam Maimonides Med J (2016) 0.75
Rate of thyroglossal duct remnant visualization after total thyroidectomy for differentiated thyroid carcinoma and its impact on clinical outcome of radioactive iodine (I-131) ablation. Indian J Nucl Med (2015) 0.75
Recurrent thyroid cancer. Ann Surg (1995) 0.75
Radioguided occult lesion localization for locally recurrent thyroid carcinoma. Eur Arch Otorhinolaryngol (2017) 0.75
Management and outcome of clinically evident neck recurrence in patients with papillary thyroid cancer. Clin Endocrinol (Oxf) (2017) 0.75
Bronchoscopic interventions combined with percutaneous modalities for the treatment of thyroid cancers with airway invasion. Eur Arch Otorhinolaryngol (2014) 0.75
Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? J Nucl Med (1990) 4.23
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab (1986) 2.70
Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc (1986) 1.84
Radioimmunoassay for measurement of thyroglobulin in human serum. J Clin Invest (1973) 1.74
Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery (1985) 1.23
Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery (1988) 1.20
Papillary thyroid carcinoma: factors influencing prognosis and current therapy. Semin Oncol (1987) 1.14
Thyroid cancer: the case for total thyroidectomy. Eur J Cancer Clin Oncol (1988) 1.09
Management of local recurrence in well-differentiated thyroid carcinoma. J Surg Res (1992) 1.01
Value of post-therapy whole-body I-131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose I-131 therapy. Clin Nucl Med (1989) 0.99
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg (1986) 0.95
Radioiodine and radiotherapy in the management of thyroid cancers. Otolaryngol Clin North Am (1990) 0.88
Surgical strategy in thyroid carcinoma: a clinical review. Acta Chir Scand (1986) 0.85
Modified radical neck dissection for metastatic carcinoma of the thyroid. A reappraisal. Am J Surg (1985) 0.83
Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients. World J Surg (1991) 0.82
Factors affecting the prognosis of patients with carcinoma of the thyroid. Surg Gynecol Obstet (1980) 0.80
Long-term management of differentiated thyroid cancer. Endocrinol Metab Clin North Am (1990) 0.80
Younger women with breast carcinoma have a poorer prognosis than older women. Cancer (1996) 3.54
Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42
Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer (1975) 3.26
Malignant peripheral nerve sheath tumors. A clinicopathologic study of 28 cases. Cancer (1993) 2.89
Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med (1978) 2.69
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Giant condyloma acuminatum (Buschke-Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum (1994) 2.04
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Proceedings: Treatment of minimal breast cancer. Cancer (1974) 1.78
Anorectal melanoma. Cancer (1981) 1.77
Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions. J Am Coll Surg (1996) 1.77
Paraproteinemia and reticulum cell sarcoma in an inbred mouse strain. Science (1966) 1.65
Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow). Ann Surg (1975) 1.52
Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases. Am J Surg (1978) 1.49
Hepatic resection for metastasis from colorectal cancer. Dis Colon Rectum (1978) 1.44
T-cell deficiency in patients with squamous cell cancer of the head and neck. Am J Surg (1975) 1.40
Immunogenic properties of reticulum cell sarcomas of SJL/J mice. J Natl Cancer Inst (1970) 1.30
Diagnosis and management of giant intrasacral schwannoma. Cancer (1992) 1.28
A rationale for expanding the endpoints for clinical trials in advanced pancreatic carcinoma. Cancer (1996) 1.27
Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma. Ann Surg (1995) 1.24
Bilateral breast cancer. Risk reduction by contralateral biopsy. Ann Surg (1985) 1.22
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients. Int J Cancer (2001) 1.20
Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma. Cancer (1993) 1.20
Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies. Arthritis Rheum (1983) 1.19
Abdominal sacral resection of locally recurrent rectal cancer. Ann Surg (1981) 1.16
Immunologic reactivity in patients with primary operable breast cancer. Cancer (1978) 1.10
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Pelvic recurrence of rectal cancer. Options for curative resection. Ann Surg (1987) 1.07
Is carcinoma of the gallbladder a curable lesion? Ann Surg (1982) 1.05
Pelvic exenteration for recurrent rectal cancer. Adv Surg (1996) 1.02
Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer? Surgery (1981) 1.00
Pleural mesothelioma. Cancer (1976) 0.99
Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg (1992) 0.97
Isolated pelvic perfusion for unresectable cancer using a balloon occlusion technique. Arch Surg (1993) 0.97
Total thyroidectomy does not enhance disease control or survival even in high-risk patients with differentiated thyroid cancer. Ann Surg (1998) 0.96
The acute and chronic effects of alcohol on the human immune system. Surg Gynecol Obstet (1975) 0.96
Fine needle aspiration cytology in lieu of open biopsy in management of primary breast cancer. Ann Surg (1984) 0.96
Surgical management and treatment of gastric and duodenal fistulas. Surg Clin North Am (1996) 0.96
Thyroid cancer: some basic considerations. Am J Surg (1981) 0.95
Immune reactivity in patients with colorectal cancer: assessment of biologic risk by immunoparameters. Cancer (1980) 0.95
Rectal injuries. J Trauma (1969) 0.94
Prognostic evaluation of regional lymph node morphology colorectal cancer. Am J Surg (1975) 0.93
Thin < or = 1 mm level III and IV melanomas are higher risk lesions for regional failure and warrant sentinel lymph node biopsy. Ann Surg Oncol (2000) 0.92
Surgical adjuvant therapy of malignant melanoma with corynebacterium parvum. Cancer (1981) 0.92
Intravenous Corynebacterium parvum: an adjunct to chemotherapy for resistant advanced ovarian cancer. Cancer (1977) 0.91
Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients. Cancer (1986) 0.91
The impact of histopathology on nodal metastases in minimal breast cancer. Arch Surg (1997) 0.91
Immunologic reactivity and prognosis in breast cancer. Cancer (1980) 0.91
Colonoscopy: an essential monitoring technique after resection of colorectal cancer. Am J Surg (1983) 0.91
Localized carcinoma of the external ear is an unrecognized aggressive disease with a high propensity for local regional recurrence. Am J Surg (1992) 0.90
Age correlates with increased frequency of high risk factors in elderly patients with thyroid cancer. Am J Surg (1995) 0.90
Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer (1985) 0.90
Squamous cell carcinoma in the immunosuppressed patient: Fanconi's anemia. Laryngoscope (1985) 0.89
Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol (1998) 0.89
Prognostic analysis of survival in small breast cancers. J Am Coll Surg (1998) 0.88
Paclitaxel and concurrent radiation for gastric cancer. Int J Radiat Oncol Biol Phys (2000) 0.87
Multimodality approach to surgical management of locally advanced epidermoid carcinoma of the anorectum. Cancer (1981) 0.87
Preoperative radiation therapy for rectal cancer. An effective therapy in need of a clinical trial. Arch Surg (1986) 0.87
Randomized trial of Bacillus Calmette-Guérin (percutaneous administration) as surgical adjuvant immunotherapy for patients with stage-II melanoma. Ann N Y Acad Sci (1976) 0.86
Colorectal cancer. A blueprint for disease control through screening by primary care physicians. Arch Surg (1986) 0.85
Lupus erythematosus complicated by the Chiari-Frommel syndrome and autoimmune thyroiditis. Arch Intern Med (1969) 0.85
Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol (1997) 0.84
Reconstruction of full thickness chest wall defects. Ann Surg (1988) 0.84
Paclitaxel, cisplatin, and concurrent radiation for esophageal cancer. Cancer Invest (2001) 0.83
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study. J Clin Oncol (1997) 0.83
Suspected recurrent rectosigmoid carcinoma after abdominoperineal resection: MR imaging and histopathologic findings. Radiology (1989) 0.83
Cancer of the bile duct: the occult malignancy. Am J Surg (1975) 0.83
Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum. Surg Gynecol Obstet (1977) 0.82
Primary gastric lymphoma. Problems in staging and management. Am J Surg (1988) 0.82
Regression in thin malignant melanoma. Microscopic diagnosis and prognostic importance. Arch Dermatol (1985) 0.82
Synchronous colon carcinomas: molecular-genetic evidence for multicentricity. Ann Surg Oncol (1996) 0.82
Catheter tract seeding after percutaneous biliary drainage for pancreatic cancer. Cancer (1986) 0.82
Technique and guidelines for needle localization biopsy of nonpalpable lesions of the breast. Surg Gynecol Obstet (1988) 0.82
Intralesional injection of the methanol extraction residue of Bacillus Calmette-Guerin (MER) into cutaneous metastases of malignant melanoma. Cancer (1978) 0.81
Arteriovenous fistulas of major vessels in the abdomen. J Trauma (1971) 0.81
Antitumor effects of a normal human serum factor (normal human globulin fraction 1) on human tumor cells in vitro. J Natl Cancer Inst (1984) 0.81
Immunologic evaluation and prognosis in patients with head and neck cancer. Am J Surg (1977) 0.81
Severe hypoglycemia associated with terminal lymphomas. Report of five cases. Cancer (1966) 0.81
Preoperative chemotherapy and radiation therapy for stage IIIa carcinoma of the lung. Ann Thorac Surg (1992) 0.81
The influence of incubation time and mitogen concentration on lymphocyte blastogenic response: determination of conditions that maximize population differences. J Immunol (1980) 0.81
The changing mammogram. A primary indication for needle localization biopsy. Arch Surg (1986) 0.80
Systemic and adjuvant therapy for patients with pancreatic carcinoma. Cancer (1996) 0.80
Evaluation of the pathologic and prognostic correlates of estrogen receptors in primary breast cancer. Ann Surg (1982) 0.80
Repeat hepatic resection for recurrent colorectal cancer. World J Surg (1997) 0.79
Immune reactivity in primary carcinoma of the lung and its relation to prognosis. J Thorac Cardiovasc Surg (1976) 0.79
Alterations of monocyte function in neoplastic diseases. Surg Forum (1979) 0.79
Seroma prevention using fibrin glue during modified radical neck dissection in a rat model. Am J Surg (1988) 0.79
Electron microscopy of murine SJL-J disease. Int J Cancer (1969) 0.79
A new mouse model of experimental melanoma for vaccine and lymphokine therapy. Int J Oncol (1998) 0.79
DNCB reactivity and prognosis in 419 patients with malignant melanoma. Cancer (1981) 0.78
The impact of an educational workshop on colorectal screening practices. J Cancer Educ (1987) 0.78
Immunocompetence testing in patients with one of the four common operable cancers--a review. Clin Bull (1978) 0.78
Molecular oncogene markers and their significance in cutaneous malignant melanoma. Ann Surg Oncol (1998) 0.78
Has monitoring of the contralateral breast improved the prognosis in patients treated for primary breast cancer? Cancer (1986) 0.78
Changing gastric cancer treatment in the United States and the pursuit of quality. Eur J Surg Oncol (2005) 0.78
Bile duct carcinoma. Diagnosis and treatment. Ann Surg (1985) 0.78